Stone X Group Inc. Gritstone Bio, Inc. Transaction History
Stone X Group Inc.
- $2.29 Trillion
- Q3 2025
Shares
1 transactions
Others Institutions Holding GRTS
# of Institutions
5Shares Held
1.07MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY872KShares$26,1590.0% of portfolio
-
Telemetry Investments, L.L.C. New York, NY105KShares$3,1500.57% of portfolio
-
Act Capital Management, LLC Wayne, PA47.5KShares$1,4250.17% of portfolio
-
ETF Managers Group, LLC Summit, NJ27.9KShares$8370.0% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL19.9KShares$5960.0% of portfolio
About Gritstone bio, Inc.
- Ticker GRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,006,896
- Market Cap $2.19M
- Description
- Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...